COVID-19

The research demonstrates that the coronavirus enzyme PLpro physically interacts with the receptor MDA5 and inhibits the ISGylation process.

This week is National Brain Awareness Week, so Pharmacy Times® interviewed Caroline Carney, MD, MSc, FAPM, CPHQ, CMO of Magellan Health, on some of the issues surrounding the contemporary understanding of mental health and brain health.

In a recent interview with Pharmacy Times, Raj Desai, PharmD, MBA, discussed a recent COVID-19 vaccination event at Houston Methodist Sugar Land Hospital, where he is the director of pharmacy.

Community pharmacists have an essential role to play during this phase of the crisis that could further entrench them as the epicenter of care in the communities they serve.

One recent study found COVID-19 antibodies in all 20 pregnant women and their newborns.

Pharmacy Times® interviewed George Rafferty, president of corporate partnerships at AmerisourceBergen, on how large retail pharmacies have been impacted by and been able to respond to the challenges of the COVID-19 pandemic.

Health care professionals should address potential barriers to completing the COVID-19 vaccination series, including scheduling second-dose appointments at the first-dose administration and sending reminders for second-dose visits.

Results of clinical trials have shown that a nitric oxide nasal spray is both a safe and effective antiviral treatment to prevent COVID-19 transmission and symptom duration, as well as reduce symptom severity and damage in those already infected.

Adults in the United States are reporting undesired weight changes, an increase in drinking, and other negative behavior changes that may be unhealthy coping mechanisms for prolonged stress, according to a survey conducted by the American Psychological Association (APA).

Evidence demonstrates that overweight and obesity are risk factors for severe COVID-19.

Using inclusive questions, preferred terms, and language etiquette can turn the simple task of immunizing into a fulfilling patient-centered opportunity for both pharmacists and patients.

Pharmacy Times® interviewed Beth Battaglino, RN-C, CEO of HealthyWomen and a convener of the COVID-19 Vaccine Education and Equity Project, on the recent “Count Me In” digital campaign.

The emergence of COVID-19 in the past year has caused a shift in many different aspects of the health care model, forcing many different challenges to be addressed throughout.

Following the establishment of the Federal Retail Pharmacy Program by the CDC, a panel of experts sat down with Pharmacy Times® to address the implications of the Federal Retail Pharmacy Program for COVID-19 vaccinations.

However, as of 2021, the biggest concern for students at MCW is getting into a residency program in general.

Although COVID-19 tests fell by 10% during the past week, positive cases fell by a significant 12%, resulting in the ninth consecutive week of a declining national positivity rate.

A follow-up poll from the University of Michigan (U-M) found that 71% of people in their 50s, 60s, and 70s are now ready to get vaccinated against COVID-19 when a dose becomes available to them.

The Medicare payment amount for administering the COVID-19 vaccine is increasing, according to a statement from the Centers for Medicare and Medicaid Services.

There have been 15 events of deep vein thrombosis and 22 events of pulmonary embolism reported across the European Union and United Kingdom.

The investigators observed a near normal age distribution among patients with long-term COVID-19 symptoms, including children.

Danielle DiBari, the chief pharmacy officer and senior vice president of business operations for NYC Health + Hospitals, discusses some of the challenges involved in coordinating vaccine distribution across New York’s public health system.

An ongoing phase 2 clinical study has begun to vaccinate patients with a modified version of Moderna’s COVID-19 vaccine.

A recent survey showed that there is a significant preference among Americans to receive COVID-19 vaccines from a trusted health care provider, such as a pharmacist or physician.

Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, discusses how the COVID-19 pandemic has impacted the FDA’s approval process.

The potential for some people to skip the second COVID-19 vaccine dose may make more doses available to others.

Study respondents cited a distrust of the US government’s motives and transparency regarding COVID-19 and systemic racism in health care as the motivation for their distrust of the vaccines.

Pharmacists must first build trust with their communities in order to address vaccine hesitancy, according to Sally Arif, PharmD, BCPS.

In a recent statement, Walgreens announced that it has administered approximately 5 million COVID-19 vaccinations at long-term care facilities, in its stores, and through its vaccination clinics.

Pharmacy Times® interviewed Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on how to approach discussing the FDA’s expedited EUA process for COVID-19 vaccines with patients with concerns about the process.

The FDA has issued an emergency use authorization (EUA) for a COVID-19 diagnostic test that can confirm recent or prior COVID-19 infection.